Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MITA, AdvaMed Pair Up To Urge Chinese Adoption Of Updated Device Standards

This article was originally published in The Gray Sheet

Executive Summary

Many countries have already transitioned to the latest edition of the International Engineering Consortium's electromedical equipment standard, but China is one of the last major holdouts, industry reps say.

You may also be interested in...



Despite Reg Challenges, China Market Access Gradually Improving

China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.

Imaging Industry Expands Emerging Market Focus

A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector’s top lobbyist.

IEC Electromedical Safety Standard Third Edition Expected In August 2005

Manufacturers planning declarations of conformity to the third edition of the International Engineering Consortium's electromedical equipment standard should come into compliance with international risk management standard ISO 14971, panelists at a recent AAMI/FDA meeting suggested

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel